• Je něco špatně v tomto záznamu ?

MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study

S. Andreasen, Q. Tan, TK. Agander, TVO. Hansen, P. Steiner, K. Bjørndal, E. Høgdall, SR. Larsen, D. Erentaite, CH. Olsen, BP. Ulhøi, S. Heegaard, I. Wessel, P. Homøe,

. 2018 ; 473 (3) : 329-340. [pub] 20180801

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18032993
E-zdroje Online Plný text

NLK ProQuest Central od 2003-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 2011-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2003-01-01 do Před 1 rokem

Odkazy

PubMed 30069755
DOI 10.1007/s00428-018-2423-0
Knihovny.cz E-zdroje

Adenoid cystic carcinoma (ACC) is among the most frequent malignancies of the salivary gland, and is notorious for its prolonged clinical course characterized by frequent recurrences often years after initial treatment. No molecular marker has been shown to have independent prognostic value in ACC, including characteristic gene fusions involving MYB, MYBL1, and NFIB. MicroRNA has been shown to be associated with clinical outcome in numerous malignancies, including one study of ACC, warranting further validation of this class of markers in this disease. Here, we investigate the prognostic value of microRNA in two ACC cohorts: a training cohort (n = 64) and a validation cohort (n = 120) with microarray and qPCR. In the training cohort, multivariate analysis of microarray data found high expression of hsa-miR-6835-3p to be associated with reduced recurrence-free survival (RFS) (p = 0.016). Measuring the highest ranking microRNAs identified in survival analysis in the same cohort, qPCR identified high expression of hsa-miR-4676 to be associated with reduced overall survival (OS) and high expression of hsa-mir-1180 to be associated with improved RFS. This was not confirmed in the validation cohort, in which qPCR identified high expression of hsa-mir-21, hsa-mir-181a-2, and hsa-mir-152 to be associated with reduced OS and high expression of hsa-miR-374c to be associated with improved RFS. Interestingly, two distinct subsets of ACC separated in microRNA expression irrespective of gene fusion status, but without significant difference in outcome. Collectively, qPCR identified several microRNAs associated with OS and RFS, and different subsets of ACC separated according to microRNA expression, suggestive of ACC being a heterogeneous group of malignancies in its microRNA profile.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18032993
003      
CZ-PrNML
005      
20181012093508.0
007      
ta
008      
181008s2018 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00428-018-2423-0 $2 doi
035    __
$a (PubMed)30069755
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Andreasen, Simon $u Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark. Simon@Andreasen.pm. Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark. Simon@Andreasen.pm.
245    10
$a MicroRNA dysregulation in adenoid cystic carcinoma of the salivary gland in relation to prognosis and gene fusion status: a cohort study / $c S. Andreasen, Q. Tan, TK. Agander, TVO. Hansen, P. Steiner, K. Bjørndal, E. Høgdall, SR. Larsen, D. Erentaite, CH. Olsen, BP. Ulhøi, S. Heegaard, I. Wessel, P. Homøe,
520    9_
$a Adenoid cystic carcinoma (ACC) is among the most frequent malignancies of the salivary gland, and is notorious for its prolonged clinical course characterized by frequent recurrences often years after initial treatment. No molecular marker has been shown to have independent prognostic value in ACC, including characteristic gene fusions involving MYB, MYBL1, and NFIB. MicroRNA has been shown to be associated with clinical outcome in numerous malignancies, including one study of ACC, warranting further validation of this class of markers in this disease. Here, we investigate the prognostic value of microRNA in two ACC cohorts: a training cohort (n = 64) and a validation cohort (n = 120) with microarray and qPCR. In the training cohort, multivariate analysis of microarray data found high expression of hsa-miR-6835-3p to be associated with reduced recurrence-free survival (RFS) (p = 0.016). Measuring the highest ranking microRNAs identified in survival analysis in the same cohort, qPCR identified high expression of hsa-miR-4676 to be associated with reduced overall survival (OS) and high expression of hsa-mir-1180 to be associated with improved RFS. This was not confirmed in the validation cohort, in which qPCR identified high expression of hsa-mir-21, hsa-mir-181a-2, and hsa-mir-152 to be associated with reduced OS and high expression of hsa-miR-374c to be associated with improved RFS. Interestingly, two distinct subsets of ACC separated in microRNA expression irrespective of gene fusion status, but without significant difference in outcome. Collectively, qPCR identified several microRNAs associated with OS and RFS, and different subsets of ACC separated according to microRNA expression, suggestive of ACC being a heterogeneous group of malignancies in its microRNA profile.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a adenoidně cystický karcinom $x genetika $x mortalita $x patologie $7 D003528
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    12
$a fúze genů $7 D050939
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x analýza $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prognóza $7 D011379
650    _2
$a nádory slinných žláz $x genetika $x mortalita $x patologie $7 D012468
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tan, Qihua $u Unit of Human Genetics, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
700    1_
$a Agander, Tina Klitmøller $u Department of Pathology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Hansen, Thomas V O $u Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Steiner, Petr $u Department of Pathology, Charles University in Prague, Faculty of Medicine, Pilsen, Czech Republic. Bioptic Laboratory Ltd, Molecular Pathology Laboratory, Pilsen, Czech Republic.
700    1_
$a Bjørndal, Kristine $u Department of ORL-Head and Neck Surgery, Odense University Hospital, Odense, Denmark.
700    1_
$a Høgdall, Estrid $u Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
700    1_
$a Larsen, Stine Rosenkilde $u Department of Pathology, Odense University Hospital, Odense, Denmark.
700    1_
$a Erentaite, Daiva $u Department of Pathology, Aalborg University Hospital, Aalborg, Denmark.
700    1_
$a Olsen, Caroline Holkmann $u Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
700    1_
$a Ulhøi, Benedicte Parm $u Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Heegaard, Steffen $u Department of Pathology, Rigshospitalet, Copenhagen, Denmark. Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark.
700    1_
$a Wessel, Irene $u Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Homøe, Preben $u Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge, Denmark.
773    0_
$w MED00004660 $t Virchows Archiv an international journal of pathology $x 1432-2307 $g Roč. 473, č. 3 (2018), s. 329-340
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30069755 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20181008 $b ABA008
991    __
$a 20181012093959 $b ABA008
999    __
$a ok $b bmc $g 1339973 $s 1029987
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 473 $c 3 $d 329-340 $e 20180801 $i 1432-2307 $m Virchows Archiv $n Virchows Arch $x MED00004660
LZP    __
$a Pubmed-20181008

Najít záznam

Citační ukazatele

Možnosti archivace